Abstract
Phase 2 Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have